← Back to Search

Direct to patient medication brochure for Prescribing Errors

N/A
Waitlist Available
Led By Amy M Linsky, MD MSc
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-index date
Awards & highlights

Study Summary

This trial is testing whether patients who are deprescribing candidates can effectively facilitate deprescribing of potentially inappropriate medications.

Eligible Conditions
  • Prescribing Errors
  • Medical Overuse Syndrome
  • Deprescribing

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-index date
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-index date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Our Aim 1 primary quantitative outcome will be binary: deprescribing versus not
Secondary outcome measures
Deprescribing conversations

Trial Design

3Treatment groups
Experimental Treatment
Group I: Proton Pump Inhibitor (PPI)Experimental Treatment1 Intervention
Patients prescribed a PPI meeting inclusion/exclusion criteria who have a primary care appointment with a provider in the PPI cohort
Group II: Gabapentin (Gaba)Experimental Treatment1 Intervention
Patients prescribed gabapentin with a total daily dose >1800mg without exclusion criteria who have a primary care appointment with a provider in the Gaba cohort
Group III: Diabetes (DM)Experimental Treatment1 Intervention
Patients prescribed either insulin or a sulfonylurea meeting inclusion/exclusion criteria who have a primary care appointment with a provider in the DM cohort
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Direct to patient medication brochure
2021
N/A
~3370

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,610 Previous Clinical Trials
3,301,816 Total Patients Enrolled
Amy M Linsky, MD MScPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
1 Previous Clinical Trials
240 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Journal of the American Geriatrics SocietyJournal
A Narrative Review of Updates in Deprescribing Research
Zimmerman, Kristin M., and Amy M. Linsky. 2021. “A Narrative Review of Updates in Deprescribing Research”. Journal of the American Geriatrics Society. Wiley. doi:10.1111/jgs.17273.
clinicaltrials.govStudy
Engaging Patients to Promote Deprescribing
2021. "Engaging Patients to Promote Deprescribing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04294901.
~842 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top